Do white matter hyperintensities mediate the association between brain iron deposition and cognitive abilities in older people?

European Journal of Neurology

Volumn 23, Issue 7, 2016, Pages 1202-1209

  Valdes Hernandez M ^a,b   Allerhand, M ^b   Glatz, A ^a   Clayson, L ^c   Munoz Maniega S ^a,b   Gow, A ^b,d   Royle, N ^b   Bastin, M ^a,b   Starr, J ^b   Deary, I ^b   Wardlaw, J ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

ageing; cognition; iron deposits; MRI; white matter hyperintensities

Indexed keywords

IRON;

AGED; ARTICLE; BRAIN IRON DEPOSIT; BRAIN LEVEL; BRAIN SIZE; COGNITION; COGNITIVE FUNCTION TEST; COMMUNITY LIVING; HUMAN; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER HYPERINTENSITY;

EID: 84973341531     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.13006     Document Type: Article

References (34)

1. Valdes Hernandez MC, Maconick LC, Tan TMJ, Wardlaw JM. Identification of mineral deposits in the brain on radiological images: a systematic review. Eur Radiol 2012; 22: 2371–2381.
2. Ward RJ, Zucca FA, Duyn JH, Crichton RR, Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol 2014; 13: 1045–1060.
3. Penke L, Valdes Hernandez MC, Muñoz Maniega S, et al. Brain iron deposits are associated with general cognitive ability and cognitive aging. Neurobiol Aging 2012; 33: 510–551.
4. Ghadery C, Pirpamer L, Hofer E, et al. R2* mapping for brain iron: associations with cognition in normal aging. Neurobiol Aging 2015; 36: 925–932.
5. McCarthy RC, Kosman DJ. Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells. PLoS One 2014; 9: e89003.
6. Martinez-Ramirez S, Greenberg SM, Viswanathan A. Cerebral microbleeds: overview and implications in cognitive impairment. Alzheimers Res Ther 2014; 6: 33.
7. Ramonet D, Pugliese M, Rodriguez MJ, et al. Calcium precipitation in acute and chronic brain diseases. J Physio Paris 2002; 96: 307–312.
8. Rouault TA, Cooperman S. Brain iron metabolism. Semin Pediatr Neurol 2006; 13: 142–148.
9. Tosto G, Zimmerman ME, Hamilton JL, Carmichael OT, Brickman AM and Alzheimer's Disease Neuroimaging Initiative. The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment. Alzheimers Dement 2015; 11: 1510–1519.
10. Valdes Hernandez M, Booth T, Murray C, et al. Brain white matter damage in aging and cognitive ability in youth and older age. Neurobiol Aging 2013; 34: 2740–2747.
11. Yan S, Sun J, Chen Y, Selim M, Lou M. Brain iron deposition in white matter hyperintensities: a 3-T MRI study. Age (Dordr) 2013; 35: 1927–1936.
12. Glatz A, Valdes Hernandez MC, Kiker AJ, Bastin ME, Deary IJ, Wardlaw JM. Characterization of multifocal T2*-weighted MRI hypointensities in the basal ganglia of elderly, community-dwelling subjects. NeuroImage 2013; 82C: 470–480.
13. Sachdev P, Wen W, Chen X, Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology 2007; 68: 214–222.
14. Verhaaren BF, Vernooij MW, de Boer R, et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension 2013; 61: 1354–1359.
15. Poggesi A, Pasi M, Pescini F, Pantoni L, Inzitari D. Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: a review. J Cereb Blood Flow Metab 2015. doi: 10.1038/jcbfm.2015.116 [Epub ahead of print].
16. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013; 12: 483–497.
17. Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat Rev Neurosci 2013; 14: 551–564.
18. van Es ACGM, van der Grond J, de Craen AJM, Admiraal-Behloul F, Blauw GJ, van Buchem MA. Caudate nucleus hypointensity in the elderly is associated with markers of neurodegeneration on MRI. Neurobiol Aging 2008; 29: 1839–1846.
19. Valdés Hernández MC, Ritchie S, Glatz A, et al. Brain iron deposits and lifespan cognitive ability. Age (Dordr) 2015; 37: 100.
20. Daugherty AM, Raz N. Appraising the role of iron in brain aging and cognition: promises and limitations of MRI methods. Neuropsychol Rev 2015; 25: 272–287.
21. Ke Y, Qian ZM. Brain iron metabolism: neurobiology and neurochemistry. Prog Neurobiol 2007; 83: 149–173.
22. Valdes-Hernandez MC, Allan J, Glatz A, et al. Exploratory analysis of dietary intake and brain iron accumulation detected using magnetic resonance imaging in older individuals: the Lothian Birth Cohort 1936. J Nutr Health Aging 2014; 19: 64–69.
23. Aribisala BS, Morris Z, Eadie E, et al. Blood pressure, internal carotid artery flow parameters and age-related white matter hyperintensities. Hypertension 2014; 63: 1011–1018.
24. Cordonnier C, Potter GM, Jackson CA, et al. Improving interrater agreement about brain microbleeds. Development of the Brain Observer MicroBleed Scales (BOMBS). Stroke 2009; 49: 94–99.
25. Valdes Hernandez MC, Morris Z, Dickie DA, et al. Close correlation between quantitative and qualitative assessments of white matter lesions. Neuroepidemiology 2012; 40: 13–22.
26. Wen W, Sachdev P. The topography of white matter hyperintensities on brain MRI in healthy 60- to 64-year-old individuals. NeuroImage 2004; 22: 144–154.
27. Valdes Hernandez MC, Maconick LC, Munoz Maniega S, et al. A comparison of location of acute symptomatic versus ‘silent’ small vessel lesions. Int J Stroke 2015; 10: 1044–1050.
28. Ogg RJ, Steen RG. Age related changes in brain T1 are correlated with putative iron concentration. Magn Reson Med 1998; 40: 749–753.
29. Morris CM, Candy JM, Oakley AE, Bloxham C, Edwarson JA. Histochemical distribution of non-haem iron in the human brain. Acta Anat 1992; 144: 235–257.
30. Sullivan EV, Adalsteinsson E, Rohlfing T, Pfefferbaum A. Relevance of iron deposition in deep gray matter brain structures to cognitive and motor performance in healthy elderly men and women: exploratory findings. Brain Imaging Behav 2009; 3: 167–175.
31. Le Vine SM, Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci 2004; 1012: 252–266.
32. Matsusue E, Sugihara S, Fujii S, Ohama E, Kinoshita T, Ogawa T. White matter changes in elderly people: MR−pathologic correlations. Magn Reson Med 2006; 5: 99–104.
33. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration: a united approach. Lancet Neurol 2013; 12: 822–838.
34. Ke Y, Qian ZM. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2003; 2: 246–253.